Financhill
Back

iShares Core US REIT ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
63

USRT
iShares Core US REIT ETF

Last Price:
$57.11
Seasonality Move:
1.9%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.60
Seasonality Move:
36.18%
Buy
63
iShares Core US REIT ETF (USRT) is a Buy

Is iShares Core US REIT ETF a Buy, Sell or Hold?

  • The current iShares Core US REIT ETF [USRT] share price is $56.79. The Score for USRT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • USRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

USRT Stock Price Chart

What is iShares Core US REIT ETF's stock price today?

  • The iShares Core US REIT ETF share price today is $56.79
    The current trend is moderately bearish and USRT is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $71.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

USRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 39.07 Sell
Chaikin Money Flow: -204059 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 37.77 Sell
Chaikin Money Flow: -61015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.54 - 86.44) Sell
Bollinger Bands (100): (44.45 - 88.87) Buy

USRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.46 Sell
20-day SMA: 57.84 Sell
50-day SMA: 58.03 Sell
200-day SMA: 57.21 Sell
8-day EMA: 57.52 Sell
20-day EMA: 57.76 Sell
50-day EMA: 56.78 Buy
200-day EMA: 36.17 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.09 Sell
20-day SMA: 80.86 Sell
50-day SMA: 83.38 Sell
200-day SMA: 51.78 Buy
8-day EMA: 75.84 Sell
20-day EMA: 78.85 Sell
50-day EMA: 77.98 Sell
200-day EMA: 56.35 Buy

iShares Core US REIT ETF Earnings Growth & USRT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

iShares Core US REIT ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):